Chapter 14
Chapter 14
Chapter 14
Chapter 14
Feeding Patients: Hospital Food and
Enteral and Parenteral Nutrition
• The prevalence of malnutrition among hospitalized
adults is estimated at 30% to 50%, depending on the
patient population and how malnutrition is defined
(Mueller et al., 2011).
• Starvation related
• Chronic disease related
• Acute disease or injury related
• Therapeutic diets
– Therapeutic diets differ from a regular diet.
– Used for the purpose of preventing or treating
disease or illness
• Nutritional supplements
– Some patients are unable or unwilling to eat
enough food to meet their requirements.
• Nutritional supplements—(cont.)
– Categories of supplements include
o Clear liquid supplements
o Milk-based drinks
o Prepared liquid supplements
o Specially prepared foods
• Nutritional supplements—(cont.)
– Liquid supplements are
o Easy to consume
o Are generally well accepted
o Tend to leave the stomach quickly
o A good choice for between-meal snacks
a. Prepared in a blender
b. Liquid
c. Modified consistency
d. Mechanically ground
c. Modified consistency
• Nutritional supplements—(cont.)
– Liquid supplements—(cont.)
o Allow the patient to taste test several options
available
o Explain the rationale for adding supplements
and closely monitor acceptance
o Given on a rotation schedule
• Patients who
– Have problems chewing and swallowing
– Have prolonged lack of appetite
– Have an obstruction, fistula, or altered motility in
the upper gastrointestinal tract
– Are in a coma
– Have very high nutrient requirements
• Feeding route
– Depends on the patient’s medical status and the
anticipated length of time the tube feeding will be
used
– Transnasal tubes
o Nasogastric (NG) tube is the most common.
o Generally used for tube feedings of relatively
short duration
• Feeding route—(cont.)
– Ostomy feedings are preferred for permanent or
long-term feedings.
– Percutaneous endoscopic gastrostomy (PEG)
tubes are placed with the aid of an endoscope.
• Formula characteristics
– Formulary of various enteral products available
within major categories
– Are designed to provide complete nutrition
• Protein
– Enteral formulas are classified by the type
of protein they contain.
– Standard formulas
o Made from whole proteins or protein
isolates
o Provide 34 to 43 g protein/L
• Protein—(cont.)
– Variations
o High in protein
o High in calories
o Fiber enriched
o Disease-specific formulas designed for patients
with diabetes, immune system dysfunction,
renal failure, or respiratory insufficiency
• Protein—(cont.)
– Hydrolyzed protein formulas
o Completely hydrolyzed formulas contain only free
amino acids as their source of protein.
o Partially hydrolyzed formulas contain proteins that
are broken down.
o Intended for patients with impaired digestion or
absorption
o Disease-specific formulas are available for liver
failure, HIV/AIDS, and immune system support.
• Water content
– Varies with the caloric concentration
– Formulas that provide 1.0 cal/mL provide
850 mL of water per liter.
– High-calorie formulas are lower at 690 to
720 mL/L.
– Adults generally need 30 to 40 mL/kg/day.
– Need additional free water
• Other nutrients
– High-fat formulas are available for patients
with respiratory disease.
– Modified-fat formulas are designed for
patients with malabsorption.
– Diabetic formulas are available.
– Electrolyte-modified formulas for renal
disease
• Osmolality
– Determined by the concentration of sugars,
amino acids, and electrolytes
– Isotonic formulas have approximately the
same osmolality as blood.
– Some patients develop diarrhea when a
hypertonic formula is infused.
False.
• Equipment
– Tubing size and pump availability impact formula
selection.
– High-fiber formulas have a high viscosity and require a
large-bore tube (8 French or greater) to prevent clogging.
– Hydrolyzed formulas have very low viscosity.
• Delivery methods
– Formulas may be given intermittently or continuously over
a period of 8 to 24 hours.
– Type of delivery method to be used depends on the type
and location of the feeding tube, the type of formula being
administered, and the patient’s tolerance.
• Intermittent feedings
– Administered throughout the day
– Generally used for noncritical patients, home
tube feedings, and patients in rehabilitation
– More closely resemble a normal intake
– Allow the client freedom between feedings
• Intermittent feedings—(cont.)
– Gastric residuals are checked before each feeding.
– Residual volumes of 200 mL or more on two
successive assessments suggest poor tolerance.
• Bolus feedings
– Variation of intermittent feedings
– Large volume of formula delivered relatively quickly
– Often cause dumping syndrome
• Tube-feeding complications
– GI, metabolic, and respiratory complications
are possible.
– Aspiration is the most serious potential
complication.
– More common than large-volume aspirations
is a series of clinically silent small aspirations.
– Increases the risk of aspiration-related
pneumonia
a. 10-40 mL/hour
• Catheter placement
– Patient’s anticipated length of need influences
placement of the catheter.
– For short-term central PN in the hospital, a temporary
central venous catheter is placed percutaneously into
the subclavian vein.
– If PN is expected to be more than a few weeks, these
are the catheters of choice:
o A Hickman catheter or Port-A-Cath
o Peripherally inserted central catheter (PICC)
• Composition of PN
– Provide protein, carbohydrate, fat, electrolytes,
vitamins, and trace elements in sterile water.
– “Compounded” or mixed in the hospital pharmacy
– Two-in-one formula (dextrose and amino acids)
o Used by most hospitals
o Lipids given separately
– Three-in-one formula (dextrose, amino acids, and
lipids)
• Protein
– Provided as a solution of crystalline essential
and nonessential amino acids
– Amino acid formulations are available with
and without electrolytes.
– Providing adequate protein is a primary
concern when formulating PN.
– Nitrogen balance study can be used to
determine adequacy of protein intake.
• Carbohydrate
– Carbohydrate used in parenteral solutions in the
United States is dextrose monohydrate.
– Minimal amount of carbohydrate needed to spare
protein is generally accepted as 1 mg/kg/min.
– Hyperglycemia is associated with immune function
impairments and increased risk of infectious
complications.
– High carbohydrate load may also lead to excessive
carbon dioxide production.
• Fat
– Lipid emulsions
o Made from soybean oil or safflower plus soybean
oil with egg phospholipid as an emulsifier
o Isotonic
o Available in 10%, 20%, and 30% concentrations
o Significant source of calories
o Necessary to correct or prevent fatty acid
deficiency
• Medications
– Patients receiving PN may have insulin ordered
if glucose levels are above 150 to 200 mg/dL.
– Heparin may be added to reduce fibrin buildup
on the catheter tip.
– Medications should not be added to PN solutions
because of the potential incompatibilities of the
medication and nutrients in the solution.
• Administration
– Administered according to facility protocol
– Generally initiated slowly (i.e., 1 L in the first 24
hours)
– Continuous drip by pump infusion is needed to
maintain a slow, constant flow rate.
– Rapid changes in the infusion rate can cause
o Severe hyperglycemia or hypoglycemia
o Potential for coma, convulsions, or death
• Administration—(cont.)
– After the patient is stable, PN may be infused
cyclically.
– Cyclic PN allows serum glucose and insulin
levels to drop during the periods when PN is
not infused.
– To give the pancreas time to adjust to the
decreasing glucose load, the infusion rate is
tapered near the end of each cycle.
• Administration—(cont.)
– During the last hour of infusion, the rate may be
reduced by one-half to prevent rebound
hypoglycemia.
– When the patient is able to begin consuming food
orally, the amount of PN is gradually reduced to
prevent
o Metabolic complications
o Nutritional inadequacies
True.